Quantcast
Skip to content Skip to footer

Business trip: The new economy of therapeutic psychedelics

Matias Serebrinsky, co-founder and general partner at psychedelic treatment investment fund PsyMed Ventures, believes the next generation of psychedelic therapies offering greater efficacy without side-effects will redraw the battle lines in the war against mental illness

1 Comment

  • Glen Burrows
    Posted September 21, 2023 at 8:46 am

    I find it exciting that these ancient compounds that have a long history of human use in almost every culture are being rediscovered, I believe that human concopisubness developed with these chemicals and that their controlled and ritual use is of huge benefit to us.

Leave a comment

Sign Up to Our Newsletter

Be the first to know the latest updates

[yikes-mailchimp form="1"]